Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Direct Growth
Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Growth

Add To Compare

35.563 (0.473%)
NAV on July 09, 2025
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 1,282 cr
Turnover Ratio 28.44%
Expense Ratio 0.63%
Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days
Returns
  • 1M: 3.07%
  • 1Y: 13.76%
  • 3M: 11.77%
  • 3Y: 26.38%
  • 6M: -1.24%
  • 5Y: 24.09%
Min Investment 5,000
Buy Now Start SIP
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since 10 months)
ISIN INF277K019A3
Fund Family Tata
P/E Ratio 35.88
P/B Ratio 5.30
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha 4.10
Beta 0.95
R-Squared 96.42
Info Ratio 1.33
Tracking Err 3.13
Sortino 2.179
Sharpe 1.184
Std Dev 15.955
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 2.6%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 97.40%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet
-
Best Sector Healthcare Funds
NAME LATEST
NAV		 RETURNS
1y     		FUND
ASSETS		 Expense
RATIO		 RISK
Sbi
SBI Healthcare Opportunities Fund Direct Growth
497.035 20.77% 3,689 cr 0.9% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata

Data Partner
Click here to visit AMC website and
read all scheme related documents Tata Fund